Article Versions Notes

Ana G, Kelly PM, Malebari AM, Noorani S, Nathwani SM, Twamley B, Fayne D, O’Boyle NM, Zisterer DM, Pimentel EF, et al. Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer. Pharmaceuticals. 2021; 14(2):169. https://doi.org/10.3390/ph14020169

Ana, Gloria, Patrick M. Kelly, Azizah M. Malebari, Sara Noorani, Seema M. Nathwani, Brendan Twamley, Darren Fayne, Niamh M. O’Boyle, Daniela M. Zisterer, Elisangela Flavia Pimentel, and et al. 2021. "Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer" Pharmaceuticals 14, no. 2: 169. https://doi.org/10.3390/ph14020169

Ana, G., Kelly, P. M., Malebari, A. M., Noorani, S., Nathwani, S. M., Twamley, B., Fayne, D., O’Boyle, N. M., Zisterer, D. M., Pimentel, E. F., Endringer, D. C., & Meegan, M. J. (2021). Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer. Pharmaceuticals, 14(2), 169. https://doi.org/10.3390/ph14020169